It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Epigenetic alterations and metabolic dysfunction are two hallmarks of aging. However, the mechanism of how their interaction regulates aging, particularly in mammals, remains largely unknown. Here we show ELOVL fatty acid elongase 2 (Elovl2), a gene whose epigenetic alterations are most highly correlated with age prediction, contributes to aging by regulating lipid metabolism. We applied artificial intelligence to predict the protein structure of ELOVL2 and the interaction with its substrate. Impaired Elovl2 function disturbs lipid synthesis with increased endoplasmic reticulum stress and mitochondrial dysfunction, leading to key aging phenotypes at both cellular and physiological level. Furthermore, restoration of mitochondrial activity can rescue age-related macular degeneration (AMD) phenotypes induced by Elovl2 deficiency in human retinal pigmental epithelial (RPE) cells; this indicates a conservative mechanism in both human and mouse. Taken together, we revealed an epigenetic-metabolism axis contributing to aging and illustrate the power of an AI-based approach in structure-function studies.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details


1 State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China (GRID:grid.458458.0) (ISNI:0000 0004 1792 6416); University of California San Diego, Institute for Genomic Medicine, La Jolla, USA (GRID:grid.266100.3) (ISNI:0000 0001 2107 4242); Faculty of Medicine, Macau University of Science and Technology, Tapai, Macau, China (GRID:grid.259384.1) (ISNI:0000 0000 8945 4455)
2 State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China (GRID:grid.458458.0) (ISNI:0000 0004 1792 6416)
3 Macau University of Science and Technology, Tapai, State Key Laboratory of Lunar and Planetary Sciences, Macau, China (GRID:grid.259384.1) (ISNI:0000 0000 8945 4455); Sichuan University, Clinical Translational Innovation Center, West China Hospital, Chengdu, China (GRID:grid.13291.38) (ISNI:0000 0001 0807 1581)
4 Guangzhou Medical University, Guangzhou Women and Children Medical Center, Guangzhou, China (GRID:grid.410737.6) (ISNI:0000 0000 8653 1072)
5 Sichuan University, Clinical Translational Innovation Center, West China Hospital, Chengdu, China (GRID:grid.13291.38) (ISNI:0000 0001 0807 1581)
6 Sun Yat-sen University, Zhongshan Ophthalmic Center, Guangzhou, China (GRID:grid.12981.33) (ISNI:0000 0001 2360 039X)
7 Southern University of Science and Technology, Institute of Advanced Biotechnology and School of Life Sciences, Shenzhen, China (GRID:grid.263817.9) (ISNI:0000 0004 1773 1790)
8 Faculty of Medicine, Macau University of Science and Technology, Tapai, Macau, China (GRID:grid.259384.1) (ISNI:0000 0000 8945 4455)